Clinical Trials List
2024-04-20 - 2031-02-28
Phase I/II
Not yet recruiting3
Recruiting1
ICD-10C16.0
Malignant neoplasm of cardia
ICD-10C7A.092
Malignant carcinoid tumor of the stomach
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9151.0
Malignant neoplasm of cardia of stomach
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- Ming-Yu Lien 無
- Chang-Fang Chiu 無
- 王幸婷 無
- Chi-Ching Chen 無
- 王秀慈 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Hung-Yuan Yu 無
- 翁敬堯 無
- Muh-Hwa Yang 無
- 姜乃榕 無
- Tien-Hua Chen 無
- Chueh-Chuan Yen 無
- 唐振育 無
- Yi-Ping Hung 無
- 陳宥任 無
- 黃宣恩 無
- Chien-An Liu 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Chia-Jui Yen 無
- Yung-Yeh Su 無
- Chih-Chieh Yen 無
- 劉奕廷 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 莊建淮 無
- Kun-Huei Yeh 無
- 呂理駿 無
- 郭弘揚 無
- 梁逸歆 無
- TA-CHEN HUANG 無
- 陳國興 無
- Ta-Ching Chen 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
約24 participants
-
Global
約210 participants
